TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation.

[1]  Carsten Werner,et al.  Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models , 2014, Scientific Reports.

[2]  H. J. Kim,et al.  Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts , 2014, Oncogene.

[3]  S. Samsonov,et al.  Artificial extracellular matrix composed of collagen I and highly sulfated hyaluronan interferes with TGFβ(1) signaling and prevents TGFβ(1)-induced myofibroblast differentiation. , 2013, Acta biomaterialia.

[4]  C. Werner,et al.  Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.

[6]  C. Werner,et al.  A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Kohji Sato,et al.  CLP36 and RIL recruit α-actinin-1 to stress fibers and differentially regulate stress fiber dynamics in F2408 fibroblasts. , 2012, Experimental cell research.

[8]  E. Chavakis,et al.  Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. , 2012, Biomaterials.

[9]  C. Werner,et al.  Using Mean Field Theory to Guide Biofunctional Materials Design , 2012 .

[10]  J. Simon,et al.  Growth promoting substrates for human dermal fibroblasts provided by artificial extracellular matrices composed of collagen I and sulfated glycosaminoglycans. , 2011, Biomaterials.

[11]  C. Werner,et al.  Two-tier hydrogel degradation to boost endothelial cell morphogenesis. , 2011, Biomaterials.

[12]  C. Werner,et al.  Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[13]  C. Werner,et al.  FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. , 2010, Biomaterials.

[14]  C. Werner,et al.  Modular StarPEG-Heparin Gels with Bifunctional Peptide Linkers. , 2010, Macromolecular rapid communications.

[15]  C. Werner,et al.  Analytical approaches to uptake and release of hydrogel-associated FGF-2 , 2010, Journal of materials science. Materials in medicine.

[16]  J. Weitz,et al.  Update on heparin: what do we need to know? , 2010, Journal of Thrombosis and Thrombolysis.

[17]  B. Hinz,et al.  The myofibroblast: paradigm for a mechanically active cell. , 2010, Journal of biomechanics.

[18]  Carsten Werner,et al.  A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. , 2009, Biomaterials.

[19]  David J Mooney,et al.  Controlled Growth Factor Delivery for Tissue Engineering , 2009, Advanced materials.

[20]  R. Vargiolu,et al.  Characterization of the mechanical properties of a dermal equivalent compared with human skin in vivo by indentation and static friction tests , 2009, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[21]  B. Hinz,et al.  Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix , 2007, The Journal of cell biology.

[22]  B. Hinz.  Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[23]  B. Hinz,et al.  Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. , 2006, The Journal of investigative dermatology.

[24]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[25]  Robert Goldman,et al.  Growth Factors and Chronic Wound Healing: Past, Present, and Future , 2004, Advances in skin & wound care.

[26]  Horst Kessler,et al.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.

[27]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[28]  A. Metters,et al.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[30]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[31]  B. Hinz,et al.  Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. , 2001, The American journal of pathology.

[32]  K. Athanasiou,et al.  Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. , 2000, Tissue engineering.

[33]  M. Lyon,et al.  The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.

[34]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[35]  S. Vincent,et al.  S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. , 1993, Nucleic acids research.

[36]  T. McCaffrey,et al.  Transforming growth factor‐β1 is a heparin‐binding protein: Identification of putative heparin‐binding regions and isolation of heparins with varying affinity for TGF‐β1 , 1992 .

[37]  F. Welt,et al.  Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex , 1989, The Journal of cell biology.

[38]  R. Cook,et al.  Advanced Mechanics of Materials , 1985 .

[39]  P. Taupin,et al.  PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals , 2009 .

[40]  E. Cukierman,et al.  Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. , 2009, Methods in molecular biology.

[41]  F. Veronese,et al.  PEGylated Protein Drugs: Basic Science and Clinical Applications , 2009 .

[42]  J. Lévêque,et al.  Mechanical properties and Young's modulus of human skin in vivo , 2004, Archives of Dermatological Research.

[43]  G. Fields,et al.  Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. , 1996, Biopolymers.